{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:17:33Z","timestamp":1781360253929,"version":"3.54.1"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Ulcerative colitis (UC), characterized by its recurrent nature, imposes a significant disease burden and compromises the quality of life. Emerging evidence suggests that achieving clinical remission is not sufficient for long-term remission. In pursuit of a favorable prognosis, mucosal healing (MH) has been defined as the target of therapies in UC. This paradigm shift has given rise to the formulation of diverse endoscopic and histological scoring systems, providing distinct definitions for MH. Endoscopic remission (ER) has been widely employed in clinical practice, but it is susceptible to subjective factors related to endoscopists. And there\u2019s growing evidence that histological remission (HR) might be associated with a lower risk of disease flares, but the incorporation of HR as a routine therapeutic endpoint remains a debate. The integration of advanced technology has further enriched the definition of deep MH. Up to now, a universal standardized definition for deep MH in clinical practice is currently lacking. This review will focus on the definition of deep MH, from different dimensions, and analyze strengths and limitations, respectively. Subsequent multiple large-scale trials are needed to validate the concept of deep MH, offering valuable insights into potential benefits for UC patients.<\/jats:p>","DOI":"10.3389\/fmed.2024.1429427","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:36:47Z","timestamp":1722573407000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Deep mucosal healing in ulcerative colitis: how deep is better?"],"prefix":"10.3389","volume":"11","author":[{"given":"Xin","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gechong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","article-title":"Ulcerative colitis","volume":"402","author":"Le Berre","year":"2023","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American college of gastroenterology, Practice Parameters Committee","volume":"92","author":"Kornbluth","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/MIB.0000000000000582","article-title":"Mortality and causes of death in ulcerative colitis: results from 20 years of follow-up in the IBSEN study","volume":"22","author":"Hovde","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"ref4","first-page":"351","article-title":"The medical management of chronic ulcerative colitis: (section of surgery: sub-section of proctology)","volume":"30","author":"Bargen","year":"1973","journal-title":"Proc R Soc Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","article-title":"Cortisone in ulcerative colitis; final report on a therapeutic trial","volume":"2","author":"Sc","year":"1955","journal-title":"Br Med J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ejim.2011.06.017","article-title":"Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy","volume":"22","author":"L\u00f3pez-Palacios","year":"2011","journal-title":"Eur J Intern Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/192794","article-title":"Clinical study of the relation between mucosal healing and long-term outcomes in ulcerative colitis","volume":"2013","author":"Yokoyama","year":"2013","journal-title":"Gastroenterol Res Pract"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.dld.2015.01.149","article-title":"Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis","volume":"47","author":"Ikeya","year":"2015","journal-title":"Dig Liver Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/ecco-jcc\/jjv158","article-title":"Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs 1): a longitudinal cohort study","volume":"10","author":"Barreiro-de","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/ecco-jcc\/jjv180","article-title":"Mucosal healing in ulcerative colitis \u2013 when zero is better","volume":"10","author":"Boal Carvalho","year":"2016","journal-title":"J Crohns Colitis"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3109\/00365521.2016.1150503","article-title":"Effect of mucosal healing (Mayo 0) on clinical relapse in patients with ulcerative colitis in clinical remission","volume":"51","author":"Kim","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.5217\/ir.2016.14.1.37","article-title":"The predictive variable regarding relapse in patients with ulcerative colitis after achieving endoscopic mucosal healing","volume":"14","author":"Yoshino","year":"2016","journal-title":"Intest Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.3748\/wjg.v22.i21.5079","article-title":"Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse","volume":"22","author":"Nakarai","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1097\/MIB.0000000000001275","article-title":"Impact of histological and endoscopic remissions on clinical recurrence and recurrence-free time in ulcerative colitis","volume":"23","author":"Ponte","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/1756283X17722926","article-title":"The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine","volume":"10","author":"Frieri","year":"2017","journal-title":"Ther Adv Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5217\/ir.2018.16.1.55","article-title":"Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis","volume":"16","author":"Narang","year":"2018","journal-title":"Intest Res."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1038\/s41424-018-0006-7","article-title":"Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing","volume":"9","author":"Yamamoto","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/2050640617752207","article-title":"Prognostic value of histological activity in patients with ulcerative colitis in deep remission: a prospective multicenter study","volume":"6","author":"Lobat\u00f3n","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"17751","DOI":"10.1038\/s41598-019-54369-7","article-title":"Endoscopic score vs blood cell indices for determining timing of immunomodulator withdrawal in quiescent ulcerative colitis","volume":"9","author":"Takenaka","year":"2019","journal-title":"Sci Rep"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1053\/j.gastro.2020.12.024","article-title":"An international multicenter real-life prospective study of electronic Chromoendoscopy score PICaSSO in ulcerative colitis","volume":"160","author":"Iacucci","year":"2019","journal-title":"Gastroenterology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S2468-1253(21)00062-5","article-title":"Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial","volume":"6","author":"Kobayashi","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ibd\/izaa048","article-title":"Endoscopic and histological assessment, correlation, and relapse in clinically quiescent ulcerative colitis (MARQUEE)","volume":"27","author":"Osterman","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/1751-2980.13126","article-title":"External validation of the Paddington International virtual electronic Chromoendo Scopy ScOre as a good endoscopic score to define mucosal healing and predict long-term clinical outcomes in ulcerative colitis","volume":"23","author":"Ruan","year":"2022","journal-title":"J Dig Dis"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00365521.2021.1991467","article-title":"Limited endoscopic mucosal inflammation on equivalent to Mayo endoscopic subscore of 0 unaffect clinical relapse of ulcerative colitis","volume":"57","author":"Shimodaira","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/ecco-jcc\/jjac001","article-title":"Combined Histo-endoscopic remission but not endoscopic healing alone in ulcerative colitis is associated with a mucosal transcriptional profile resembling healthy mucosa","volume":"16","author":"Hern\u00e1ndez-Rocha","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/ibd\/izac075","article-title":"Histologic activity and steroid use history are risk factors of clinical relapse in ulcerative colitis with Mayo endoscopic subscore of 0 or 1","volume":"29","author":"Seong","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.gie.2022.11.019","article-title":"Usefulness of texture and color enhancement imaging in assessing mucosal healing in patients with ulcerative colitis","volume":"97","author":"Hayashi","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.3748\/wjg.v29.i47.6111","article-title":"Comparison of fecal calprotectin levels and endoscopic scores for predicting relapse in patients with ulcerative colitis in remission","volume":"29","author":"Ishida","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12876-022-02157-5","article-title":"Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis","volume":"22","author":"Viscido","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1136\/gutjnl-2014-308839","article-title":"An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis","volume":"64","author":"Manginot","year":"2015","journal-title":"Gut"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"International Organization for the Study of IBD. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2015","journal-title":"Gastroenterology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12876-016-0462-z","article-title":"Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis","volume":"16","author":"Kawashima","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/ecco-jcc\/jjv111","article-title":"The modified Mayo endoscopic score (MMES): a new index for the assessment of extension and severity of endoscopic activity in ulcerative colitis patients","volume":"9","author":"Lobat\u00f3n","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1053\/j.gastro.2013.07.024","article-title":"Reliability and initial validation of the ulcerative colitis endoscopic index of severity","volume":"145","author":"Travis","year":"2013","journal-title":"Gastroenterology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/ecco-jcc\/jjw104","article-title":"The ulcerative colitis endoscopic index of severity is useful to predict medium-to long-term prognosis in ulcerative colitis patients with clinical remission","volume":"10","author":"Arai","year":"2013","journal-title":"J Crohns Colitis"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/ecco-jcc\/jjv077","article-title":"The impact of clinical information on the assessment of endoscopic activity: characteristics of the ulcerative colitis endoscopic index of severity [UCEIS]","volume":"9","author":"Travis","year":"2015","journal-title":"J Crohns Colitis"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/gutjnl-2011-300486","article-title":"Developing an instrument to assess the endoscopic severity of ulcerative colitis: the ulcerative colitis endoscopic index of severity (UCEIS)","volume":"61","author":"Travis","year":"2012","journal-title":"Gut"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/den.12655","article-title":"Ulcerative colitis endoscopic index of severity is associated with long-term prognosis in ulcerative colitis patients treated with infliximab","volume":"28","author":"Saigusa","year":"2016","journal-title":"Dig Endosc"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/apt.13948","article-title":"Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus","volume":"45","author":"Vuitton","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/gut.2005.068809","article-title":"Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis","volume":"55","author":"Ardizzone","year":"2006","journal-title":"Gut"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/bmj.1.5375.89","article-title":"Variation between observers in describing mucosal appearances in procotolitis","volume":"1","author":"Baron","year":"1964","journal-title":"Br Med J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","article-title":"Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial","volume":"298","author":"Rachmilewitz","year":"1989","journal-title":"BMJ"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cgh.2012.08.003","article-title":"Validation of the ulcerative colitis colonoscopic index of severity and its correlation with disease activity measures","volume":"11","author":"Samuel","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1007\/s00384-021-04009-2","article-title":"Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse","volume":"36","author":"Ishida","year":"2021","journal-title":"Int J Color Dis"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"17562848221092594","DOI":"10.1177\/17562848221092594","article-title":"Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis","volume":"15","author":"Nardone","year":"2022","journal-title":"Ther Adv Gastroenterol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.gie.2022.02.012","article-title":"Reproducibility of the electronic chromoendoscopy PICaSSO score (Paddington International virtual Chromoendo Scopy ScOre) in ulcerative colitis using multiple endoscopic platforms: a prospective multicenter international study (with video)","volume":"96","author":"Cannatelli","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/s-0042-124363","article-title":"Beyond white light: optical enhancement in conjunction with magnification colonoscopy for the assessment of mucosal healing in ulcerative colitis","volume":"49","author":"Iacucci","year":"2017","journal-title":"Endoscopy"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"E41","DOI":"10.1055\/a-0990-9375","article-title":"A novel endoscopic imaging system for quantitative evaluation of colonic mucosal inflammation in patients with quiescent ulcerative colitis","volume":"8","author":"Honzawa","year":"2020","journal-title":"Endosc Int Open"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"E578","DOI":"10.1055\/a-1120-8376","article-title":"Surveillance in inflammatory bowel disease: is chromoendoscopy the only way to go? A systematic review and meta-analysis of randomized clinical trials","volume":"8","author":"Resende","year":"2020","journal-title":"Endosc Int Open"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1007\/s00464-022-09852-0","article-title":"Validation of red dichromatic imaging score (RDI score) to evaluate the severity of ulcerative colitis","volume":"37","author":"Hashimoto","year":"2023","journal-title":"Surg Endosc"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/ibd\/izx012","article-title":"Development and validation of a confocal laser Endomicroscopy-based score for in vivo assessment of mucosal healing in ulcerative colitis patients","volume":"24","author":"Gheorghe","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1053\/j.gastro.2022.10.014","article-title":"Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: the prospective ERIca trial","volume":"164","author":"Rath","year":"2017","journal-title":"Gastroenterology"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.gie.2022.08.023","article-title":"Endocytoscopy for assessing histologic inflammation in ulcerative colitis: development and prospective validation of the ELECT (ErLangen Endocytoscopy in ColiTis) score (with videos)","volume":"97","author":"Vitali","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/gastro\/gov024","article-title":"The 2\u2009+\u20091 paradigm: an efficient algorithm for central reading of Mayo endoscopic subscores in global multicenter phase 3 ulcerative colitis clinical trials","volume":"4","author":"Ahmad","year":"2016","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1136\/gutjnl-2019-320056","article-title":"Automatic, computer-aided determination of endoscopic and histological inflammation in patients with mild to moderate ulcerative colitis based on red density","volume":"69","author":"Bossuyt","year":"2020","journal-title":"Gut"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1053\/j.gastro.2020.02.012","article-title":"Development and validation of a deep neural network for accurate evaluation of endoscopic images from patients with ulcerative colitis","volume":"158","author":"Takenaka","year":"2020","journal-title":"Gastroenterology"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1097\/JCMA.0000000000000559","article-title":"Accurate diagnosis of endoscopic mucosal healing in ulcerative colitis using deep learning and machine learning","volume":"84","author":"Huang","year":"2021","journal-title":"J Chin Med Assoc"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/den.14677","article-title":"Artificial intelligence quantifying endoscopic severity of ulcerative colitis in gradation scale","volume":"36","author":"Takabayashi","year":"2023","journal-title":"Dig Endosc"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/ecco-jcc\/jjw181","article-title":"Training programs on endoscopic scoring Systems for Inflammatory Bowel Disease Lead to a significant increase in Interobserver agreement among community gastroenterologists","volume":"11","author":"Daperno","year":"2017","journal-title":"J Crohns Colitis"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/gut.47.3.404","article-title":"A reproducible grading scale for histological assessment of inflammation in ulcerative colitis","volume":"47","author":"Geboes","year":"2000","journal-title":"Gut"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ecco-jcc\/jjz107","article-title":"Faecal calprotectin predicts endoscopic and histological activity in clinically quiescent ulcerative colitis","volume":"14","author":"Hart","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/MIB.0000000000000652","article-title":"Low fecal calprotectin correlates with histological remission and mucosal healing in ulcerative colitis and colonic Crohn's disease","volume":"22","author":"Zittan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1016\/j.cgh.2020.09.017","article-title":"Histologic features of Colon biopsies (Geboes score) associated with progression of ulcerative colitis for the first 36 months after biopsy","volume":"19","author":"Magro","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/apt.15568","article-title":"Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission","volume":"51","author":"Cushing","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/ecco-jcc\/jjz123","article-title":"Comparing the continuous Geboes score with the Robarts histopathology index: definitions of histological remission and response and their relation to Faecal calprotectin levels","volume":"14","author":"Magro","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1136\/gut.32.2.174","article-title":"Microscopic activity in ulcerative colitis: what does it mean?","volume":"32","author":"Riley","year":"1991","journal-title":"Gut"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"8891937","DOI":"10.1155\/2020\/8891937","article-title":"Histopathologic parameters at diagnosis as early predictors of histologic remission along the course of ulcerative colitis","volume":"2020","author":"Yamamoto-Furusho","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.3748\/wjg.v24.i38.4384","article-title":"Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis","volume":"24","author":"Urushikubo","year":"2018","journal-title":"World J Gastroenterol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/gutjnl-2015-310393","article-title":"Development and validation of a histological index for UC","volume":"66","author":"Mosli","year":"2017","journal-title":"Gut"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1136\/gutjnl-2018-317547","article-title":"Definitions of response and remission for the Robarts histopathology index","volume":"68","author":"Pai","year":"2019","journal-title":"Gut"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1053\/j.gastro.2021.02.035","article-title":"An international consensus to standardize integration of histopathology in ulcerative colitis clinical trials","volume":"160","author":"Ma","year":"2021","journal-title":"Gastroenterology"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1136\/gutjnl-2016-312722","article-title":"A practical guide to assess the Nancy histological index for UC","volume":"65","author":"Marchal-Bressenot","year":"2016","journal-title":"Gut"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.14309\/ajg.0000000000000437","article-title":"Histological remission in ulcerative colitis: under the microscope is the cure","volume":"115","author":"Chateau","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/ecco-jcc\/jjab063","article-title":"Histological disease activity measured by the Nancy index is associated with long-term outcomes in patients with ulcerative colitis","volume":"15","author":"D'Amico","year":"2021","journal-title":"J Crohns Colitis"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/ecco-jcc\/jjaa010","article-title":"Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis","volume":"14","author":"Magro","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1136\/gutjnl-2021-326376","article-title":"PICaSSO histologic remission index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system","volume":"71","author":"Gui","year":"2022","journal-title":"Gut"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/ecco-jcc\/jjad110","article-title":"Neutrophil-only histological assessment of ulcerative colitis correlates with endoscopic activity and predicts long-term outcomes in a multicenter study","volume":"17","author":"Parigi","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3760\/cma.j.cn101480-20220818-00129","article-title":"The value of PICaSSO histological remission index in the evaluation of ulcerative colitis","volume":"7","author":"Xin","year":"2023","journal-title":"Chinese Journal of Inflammatory Bowel Diseases"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1055\/s-0034-1391863","article-title":"Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings","volume":"47","author":"Iacucci","year":"2015","journal-title":"Endoscopy"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/DCR.0b013e31819ad456","article-title":"Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis","volume":"52","author":"Hefti","year":"2009","journal-title":"Dis"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.sempedsurg.2007.04.005","article-title":"Pathology of inflammatory bowel disease","volume":"16","author":"Gramlich","year":"2007","journal-title":"Semin Pediatr Surg"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/j.gastro.2020.10.024","article-title":"Central Reading of ulcerative colitis clinical trial videos using neural networks","volume":"160","author":"Gottlieb","year":"2021","journal-title":"Gastroenterology"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"874","DOI":"10.14309\/ajg.0000000000000183","article-title":"A treat-to-target update in ulcerative colitis: a systematic review","volume":"114","author":"Ungaro","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1038\/ajg.2016.418","article-title":"Histological disease activity as a predictor of clinical relapse among patients with ulcerative colitis: systematic review and Meta-analysis","volume":"111","author":"Park","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/ecco-jcc\/jjaa068","article-title":"Segmental histological normalisation occurs in ulcerative colitis but does not improve clinical outcomes","volume":"14","author":"Christensen","year":"2020","journal-title":"J Crohns Colitis"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cgh.2013.07.022","article-title":"Histologic remission: the ultimate therapeutic goal in ulcerative colitis?","volume":"12","author":"Peyrin-Biroulet","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1053\/j.gastro.2020.08.037","article-title":"Relationship between combined histologic and endoscopic endpoints and efficacy of Ustekinumab treatment in patients with ulcerative colitis","volume":"159","author":"Li","year":"2020","journal-title":"Gastroenterology"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1080\/00365521.2018.1482956","article-title":"The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis","volume":"53","author":"Carlsen","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ueg2.12185","article-title":"PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis","volume":"10","author":"Nardone","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/ecco-jcc\/jjad015","article-title":"Patient-reported outcomes and disability are associated with histological disease activity in patients with ulcerative colitis: results from the APOLLO study","volume":"17","author":"Verstockt","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/ecco-jcc\/jjac037","article-title":"Mental health, work Presenteeism, and exercise in inflammatory bowel disease","volume":"16","author":"Sciberras","year":"2022","journal-title":"J Crohns Colitis"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ecco-jcc\/jjac145","article-title":"What are the unmet needs and Most relevant treatment outcomes according to patients with inflammatory bowel disease? A qualitative patient preference study","volume":"17","author":"Schoefs","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/ueg2.12288","article-title":"Ulcerative colitis: impact of early disease clearance on long-term outcomes \u2013 a multicenter cohort study","volume":"10","author":"D'Amico","year":"2022","journal-title":"United European Gastroenterol J"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"izad159","DOI":"10.1093\/ibd\/izad159","article-title":"Disease clearance as a new outcome in ulcerative colitis: a systematic review and expert consensus","volume":"2023","author":"D'Amico","year":"2023","journal-title":"Inflamm Bowel Dis"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/ecco-jcc\/jjad033","article-title":"Combined histological and endoscopic endpoints at post-induction lack additional prognostic value compared with endoscopic improvement alone in ulcerative colitis: a post hoc analysis of the VARSITY study","volume":"17","author":"Wong","year":"2023","journal-title":"J Crohns Colitis"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.cgh.2022.02.032","article-title":"IOIBD recommendations for clinical trials in ulcerative Proctitis: the PROCTRIAL consensus","volume":"20","author":"Caron","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/jgh.13923","article-title":"Limited uptake of ulcerative colitis \"treat-to-target\" recommendations in real-world practice","volume":"33","author":"Bryant","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"892","DOI":"10.5152\/tjg.2023.22812","article-title":"Evaluation of mucosal healing in ulcerative colitis by fecal calprotectin vs. fecal immunochemical test: a systematic review and Meta-analysis","volume":"34","author":"Hu","year":"2023","journal-title":"Turk J Gastroenterol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"211141","DOI":"10.7754\/Clin.Lab.2021.211141","article-title":"PLR and IL-8 were potential markers in differential diagnosis and disease activity in ulcerative colitis patients","volume":"68","author":"He","year":"2022","journal-title":"Clin Lab"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/jgh.15813","article-title":"Mucosal interleukin-8 expression as a predictor of subsequent relapse in ulcerative colitis patients with Mayo endoscopic subscore 0","volume":"37","author":"Uchiyama","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000527846","article-title":"Positioning and usefulness of biomarkers in inflammatory bowel disease","volume":"104","author":"Sakurai","year":"2023","journal-title":"Digestion"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.gastro.2022.12.007","article-title":"AGA clinical practice guideline on the role of biomarkers for the Management of Ulcerative Colitis","volume":"164","author":"Singh","year":"2023","journal-title":"Gastroenterology"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/ibd\/izaa062","article-title":"Novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF: neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio","volume":"26","author":"Bertani","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12876-020-01229-8","article-title":"Serum amyloid a is a better predictive biomarker of mucosal healing than C-reactive protein in ulcerative colitis in clinical remission","volume":"20","author":"Wakai","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"11086","DOI":"10.1038\/s41598-021-90441-x","article-title":"Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease","volume":"11","author":"Yasutomi","year":"2021","journal-title":"Sci Rep"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/ecco-jcc\/jjv075","article-title":"Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity","volume":"9","author":"Srivastava","year":"2025","journal-title":"J Crohns Colitis"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1429427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T04:36:53Z","timestamp":1722573413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1429427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":106,"alternative-id":["10.3389\/fmed.2024.1429427"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1429427","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"article-number":"1429427"}}